Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… DIFLUNISAL Tablet; 500MG DIFLUNISAL Geneva 018445 DIFLUNISAL Tablet; 250MG DOLOBID MERCK 018445 DIFLUNISAL Tablet; 500MG DOLOBID MERCK 073562 DIFLUNISAL Tablet; 250MG DIFLUNISAL Roxane 073563 DIFLUNISAL Tablet; 500MG DIFLUNISAL Roxane 073679 DIFLUNISAL Tablet; 250MG DIFLUNISAL Teva 073673 DIFLUNISAL Tablet; 500MG DIFLUNISAL Teva 074400 DIFLUNISAL Tablet; 250MG DIFLUNISAL Watson 074400 DIFLUNISAL Tablet; 500MG DIFLUNISAL Watson | Dolobid (diflunisal) Tablets, Merck Research, Labeling Revision | Dolobid (diflunisal) Tablets, Merck & Co., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com